Biomarkers · Coagulation
Coagulation Factor VIII
Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Coagulation Factor VIII and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Published risk of death1.63×top third vs bottom third of factor VIII, fully risk-factor adjusted (95% CI 1.35–1.96) · Glasgow MONICA: men and women aged 30-74 without baseline CVD (382 to 1,123 per assay), followed 15-20 years
Sources
- Risk curve: Lowe 2022 (PMID 35707625): all-cause HR 1.63 (1.35-1.96) top third vs bottom third of factor VIII, fully risk-factor adjusted. Scaled to published population values.
- Lowe et al. Associations of Hemostatic Variables with Cardiovascular Disease and Total Mortality: The Glasgow MONICA Study. TH open : companion journal to thrombosis and haemostasis. 2022;6:e107-e113.
Map Coagulation Factor VIII against another biomarker.
Related markers: Angiopoietin-2 · Coagulation Factor VIIc · D-dimer · Plasma Viscosity · Plasminogen Activator Inhibitor-1 (PAI-1) · Soluble ICAM-1 (sICAM-1) · von Willebrand Factor (vWF)